Journal
BIOORGANIC & MEDICINAL CHEMISTRY
Volume 12, Issue 13, Pages 3471-3483Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2004.04.035
Keywords
dopamine; agonists; D-4 receptor; piperazine
Ask authors/readers for more resources
Diaryl piperazine acetamides were identified as potent and selective dopamine D-4 receptor agonists. Our strategy is based on an amide bond reversal of an acid sensitive, dopamine D4 receptor partial agonist, PD 168077. This reversal provided compounds with excellent potency and improved stability. Systematic evaluation of the substitution on the aryl piperazine portion revealed a significant effect on functional activity. The synthesis and biological activity of these new dopamine D4 agonists is discussed. (C) 2004 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available